Kwality Pharmaceuticals539997Board meeting scheduled

Board Meeting on November 12, 2026 to consider and approve unaudited Q2 and half-year results

Board meeting scheduled for Thursday, November 12, 2026 at 10:30 A.M. at the registered office in Amritsar.

By ScoutQuest · Thu 5 Nov 2026, 1:19 PM IST · 2 min read

Board Meeting Date: Thursday, November 12, 2026 at 10:30 A.M.
Agenda: Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026
Trading Window: closed till 48 hours after the results are declared on November 12, 2026

What the update says

The company has given notice that a meeting of its Board of Directors is scheduled for Thursday, November 12, 2026. The meeting will be held at the registered office at Village Nagkalan, Majitha Road, Amritsar, Punjab-143601, starting at 10:30 A.M.

Agenda of the meeting

To consider and approve the Unaudited Standalone and Consolidated Financial Results of the company for the quarter and half year ended September 30, 2026.
To transact any other business with the permission of the Chair.

Why standalone and consolidated both matter

The board will look at two sets of numbers, one for the company on its own (standalone) and one for the company together with its subsidiaries (consolidated). Investors usually track the consolidated numbers to see the group's overall performance, and the standalone numbers to see the main operating entity.

Trading window

In continuation of its earlier intimation dated September 28, 2026 on closure of the trading window, the company said the trading window for dealing in its shares will remain closed for all designated persons, their immediate relatives and other connected persons till 48 hours after the financial results are declared on November 12, 2026.

What this means for a retail investor

This is a meeting notice, not the results. The actual profit, revenue and margin figures for the September 2026 quarter and half year will come with the results declared after the meeting.
The trading window restriction applies to designated persons and connected persons of the company, not to the general investing public.
The agenda also allows other business with the permission of the Chair, so any additional item, if taken up, would be known from the outcome of the meeting.

How to read the news

A scheduled board meeting to approve quarterly results is a routine, calendar-driven disclosure. The information that matters for judging performance is the results themselves, which this notice does not contain.

Also from Kwality Pharmaceuticals